DO
DOCT.LSE L&G Healthcare Breakthrough UCITS ETF
- USD
No recent price
- Total assets
- 56.9M
- Expense ratio
- 0.50%
- Dividend yield
- -
- 1-year return
- +36.73%
- Holdings
- 60
- Since
- 2019
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does DOCT.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (77.1%)
- Largest sector: Healthcare (96.5%)
- Largest region: North America (80.7%)
- Top 3 holdings: 7.6% of the fund
Asset allocation
- US stocks 77.1%
- Non-US stocks 19.9%
- Cash 0.1%
Top holdings
- GRAIL, LLC 2.88%
- Twist Bioscience Corp 2.40%
- CareDx Inc 2.34%
- Natera Inc 2.31%
- Glaukos Corp 2.20%
L&G Healthcare Breakthrough UCITS ETF performance
Sharpe ratio 1.15- This year
- +29.21%
- 1 year
- +36.73%
- 3 years
- +26.36%
- 5 years
- -0.30%
Volatility 17.5% over 1 year and 19.3% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DOCT.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
L&G Healthcare Breakthrough UCITS ETF top holdings
22.6% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| GRAIL, LLC GRAL.US | Healthcare | United States | 2.88% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 2.40% |
| CareDx Inc CDNA.US | Healthcare | United States | 2.34% |
| Natera Inc NTRA.US | Healthcare | United States | 2.31% |
| Glaukos Corp GKOS.US | Healthcare | United States | 2.20% |
| Moderna Inc MRNA.US | Healthcare | United States | 2.16% |
| Guardant Health Inc GH.US | Healthcare | United States | 2.13% |
| Intuitive Surgical Inc ISRG.US | Healthcare | United States | 2.12% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 2.11% |
| Tempus AI, Inc. Class A Common Stock TEM.US | Healthcare | United States | 1.94% |
The 10 largest of 60 holdings.
DOCT.LSE sector exposure
- Healthcare96.5%
- Technology1.5%
Share of the stocks in the fund.
DOCT.LSE regional exposure
- North America80.7%
- Europe Developed14.3%
- Asia Emerging2.5%
- United Kingdom2.0%
- Japan1.2%
Share of the stocks in the fund.
Company size
Average market cap 18.2B- Mega cap1.6%
- Big cap19.6%
- Medium cap35.9%
- Small cap27.9%
- Micro cap12.6%
L&G Healthcare Breakthrough UCITS ETF fund profile
- Fund name
- L&G Healthcare Breakthrough UCITS ETF
- Ticker
- DOCT.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Jun 26, 2019
- Trading currency
- USD
- Expense ratio
- 0.50%